Download presentation
Presentation is loading. Please wait.
Published byPhillip Bruce Modified over 9 years ago
2
Management Team Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager Professor Mathew Brown: Research and Development Director Professor of Cell Biology & Applied Virology Dr Amos Iorliam: Operations Director MBA Harvard University, LLP Ruth Kennedy-Walker: Finance Director MBA, FCA, Chartered accountant: PWC
3
COST OF PIPELINE CORROSION COST OF MIC £12.1 Billion £3.6 Billion Cost of Corrosion in the Oil Industry
4
Microbial Influenced Corrosion
5
Metabolites Microbial Influenced Corrosion
6
COST OF PIPELINE CORROSION COST OF MIC £12.1 Billion £3.6 Billion £1.9 Billion Cost of MIC in the Oil Industry
7
MIC Mitigation/Maintenance Dewatering Physical Cleaning (Pigging) Flushing/Addition of Biocides Introduction of Chemical Inhibitors Internal pipeline coatings
8
MIC Phage Therapy
9
Lab Scale Results: Reduced Biofilm Formation by up to 20% Reduced MIC Causing Bacteria by 60% Reduced Corrosion by up to 25% Phage Therapy Vs. Biocides/Inhibitors Phage AdditionBiocide Addition
10
Market Opportunity £1.9 Billion p.a£475 Million p.a
11
Where We Have Come From? 200820092010201120122013 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 EPSRC Advanced Research Fellowship 1/9/2008 1/3/2013 - 1/3/2013 International Patents Filed in Target Nations 1/5/2013 - 1/5/2013 UK IP Granted 1/11/2010 - 1/11/2010 UK Priority Applications 16/9/2013 - 16/9/2013 IP License and Research Concordat Agreed with University 1/9/2011 - 1/9/2012 Phage Application Experiment 1/9/2009 - 1/9/2011 Development of Lab Scale Culture Techniques 1/9/2008 - 1/9/2010 Identification and Isolation of Major MIC causing Bacteria and Associated Phages
12
Business Strategy: Years 1 - 3 20132014201520162017 End of Year 3 1/1/2017 End of Year 2 1/1/2016 End of Year 1 1/1/2015 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 1/1/2014 - 1/1/2017 Continued R & D 1/1/2016 - 1/1/2017 Identify Potential Licensees/ Building Market Presence 1/7/2014 - 1/7/2016 Scale Up of Phage Application 1/7/2014 - 1/3/2017 Production of Phage Culture 1/1/2014 - 1/7/2014 Scale Up of Phage Culturing Techniques
13
Intellectual Property 20102011201220132014201520162017 End of Year 3 1/1/2017 End of Year 2 1/1/2016 End of Year 1 1/1/2015 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 1/12/2014 - 1/11/2016 Patents Granted in Target Nations 1/3/2013 - 1/3/2013 International Patents Filed in Target Nations 1/9/2011 - 1/9/2011 International PCT Applications 1/5/2013 - 1/5/2013 UK IP Granted 1/11/2010 - 1/11/2010 UK Priority Applications
14
Expenditure: Years 1 - 3
15
Projected Income: Years 4 - 10
16
Growth and Future Markets Gas Oil Wastewater Drinking water
17
Thank You
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.